ABSTRACT. To identify single-nucleotide polymorphisms that contribute to the genetic susceptibility to schizophrenia, we examined the potential association between schizophrenia and 9 single nucleotide polymorphisms (rs1530351, rs4791230, rs2869577, rs8077696, rs8070231, rs2292592, rs9916525, rs1122079, and rs4790953) in the G-protein signaling 9 gene. The participants included 395 schizophrenia subjects and 400 healthy controls. The selected single nucleotide polymorphisms were genotyped using mass spectrometry techniques. The allelic or genotypic frequencies of the rs4791230 (promoter region) polymorphisms in subjects with schizophrenia were significantly different from those in healthy controls. The subjects with schizophrenia had a significantly higher frequency of the G allele (P = 0.030, odds ratio = 1.589, 95% confidence interval = 1.042-2.422) of rs4791230. Strong linkage disequilibrium was observed in 4 blocks 8459 SNPs of RGS9 in schizophrenia ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (3): 8458-8465 (2015) (D' > 0.9). Significantly fewer T-A (rs1530351-rs4791230) haplotypes (P = 0.029) were found in subjects with schizophrenia. These findings suggest a role of G-protein signaling 9 polymorphisms in schizophrenia among Han Chinese and may be informative for future genetic or neurobiological studies on schizophrenia.
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INTRODUCTION
Schizophrenia is a chronic, debilitating psychotic mental disorder that affects approximately 1% of the population worldwide (Mueser and McGurk, 2004) . The disease is characterized by positive symptoms, such as delusions, hallucinations, and thought disorder, and by negative symptoms, such as social withdrawal, apathy, and cognitive impairment. Family, adoption, and twin studies have consistently demonstrated a substantial genetic influence on the development of schizophrenia, with inherited risk estimates in the range of 80% (Cannon, 2005; Kukshal et al., 2012) . Previous studies have suggested that polymorphisms in the regulator of G-protein signaling 9 (RGS9) may be related to schizophrenia (Liou et al., 2009) .
The receptors for dopamine are members of the G-protein coupled receptor superfamily (Missale et al., 1998) , and G-protein coupled receptor signal termination can be enhanced by members of a family of proteins known as RGSs (Berman and Gilman, 1998) . RGS9-2 is highly expressed in the striatum and plays a role in modulating dopaminergicmediated signaling cascades (Gold et al., 1997; Rahman et al., 2003) . The supersensitivity of D2 receptors, as observed in RGS9 knockout mice, is a common feature of psychosis (Rahman et al., 2003) . Consistently, RGS9 expression was diminished in amphetaminetreated rat model of schizophrenia (Seeman et al., 2007) . Previous studies have shown that the expression of RGS9-2 in the postmortem brain of patients with schizophrenia was lower than that in controls (Mirnics et al., 2001; Seeman et al., 2007) . These findings provide additional support implicating RGS9 as a candidate gene in schizophrenia.
The RGS9 gene (17q21-25, 1.1 Mb) contains 18 exons with intron-exon junctions conforming to splice-site consensus sequences (Zhang et al., 1999) , and linkage studies have demonstrated that the region is important because of its relationship with major mental illness (Rousset and Raymond, 1995; Escamilla et al., 2009; Clarke et al., 2011) . A previous study found no association between the regulator of RGS9 and schizophrenia in a Jewish population (Greenbaum et al., 2010) . However, a weak association between RGS9 (rs4790953, near the 3' region) and antipsychotic-induced tardive dyskinesia was reported in a sample from Taiwan (Liou et al., 2009) . Using haplotype analyses, researchers found a significant association between the haplotype consisting of rs8077696, rs8070231, and rs2292593 in the RGS9 gene (Liou et al., 2009) . Based on the crucial role of RGS9 in mental illness, we investigated 9 SNPs (rs8077696, rs8070231, rs2292593, rs2292592, rs9916525, rs11220799, rs1530351, rs4791230, and rs2869577) in a Chinese population to verify the putative association between RGS9 polymorphisms and schizophrenia. 
MATERIAL AND METHODS

Subjects
A total of 395 unrelated patients with schizophrenia (N = 226 males and 169 females; mean age of onset, 32.3 ± 9.6 years) were recruited from the mental health center of the First Affiliated Hospital, Xi'an Jiaotong University and the Xi'an Mental Health Center. All diagnoses were assigned following a standard procedure. After providing written informed consent, each subject was assessed using the Structured Clinical Interview for DSM-IV Axis I disorder, which was administered by experienced psychiatrists. Standard diagnostic assessments were supplemented with clinical information obtained by reviewing medical records and interviewing family informants. Detailed information concerning the onset and course of clinical disorders, the presence of personality disorders and mental retardation, and a brief description of the subject's psychosocial and occupational functioning during the course of the illness were presented to a consensus diagnostic group, which included at minimum 3 trained psychiatrists with Diagnostic and Statistical Manual of Mental Disorders, 4th revision (DSM-IV) diagnostic experience, as well as other trained Structured Clinical Interview for DSM-IV Axis I disorder raters. All available information (personal history, hospital record, and family-history report) was used to reach a consensus-related DSM-IV diagnosis. Participants were excluded if they: met the DSM-IV criteria for an additional Axis I disorder; had a history of substance-induced psychotic disorders, learning disabilities, head injuries, and other symptomatic psychoses; were taking other prescribed medications that could affect the central nervous system; had a history of seizures, hematological diseases, or severe liver or kidney impairment; or were pregnant. The study complied with the guidelines of our local Medical Ethical Committee, and all participants recruited in this study provided written informed consent.
A total of 400 healthy blood donors (N = 232 males and 168 females; mean age, 33.1 ± 6.8 years) were recruited at the First Hospital Affiliated to the Medical College of Xi'an Jiaotong University. Subjects who had psychotic disorders, participated in other studies, or suffered from chronic brain diseases were excluded. All participants were Han Chinese from Shanxi Province and were not genetically related. Written informed consent was obtained from all participants. The study protocol was approved by the Ethical Committee of Xi'an Jiaotong University, Xi'an, China.
Single nucleotide polymorphism (SNP) selection
SNPs in the promoter region, untranslated regions, exons, introns, and near the 3' end of the RGS9 gene were systematically screened. The RGS9 gene with a genomic length of 1.1 Mb and 10 SNPs selected, which were selected for genotyping, are shown in Table 1 . Preliminary analysis was performed using the HapMap data. Using the Haploview software v4.2 and a minor allele frequency cut-off ≥5% (HapMap Data Release 27), TagSNPs were examined in Chinese Han in Beijing population. The linkage disequilibrium pattern of this gene was determined in the Chinese population using the preliminary data from the HapMap. These SNPs were analyzed in an association study. 
Genotyping
Three to five milliliters peripheral blood was collected into tubes coated with EDTA. Genomic DNA was extracted from blood leukocytes using the EZNA™ Blood DNA Midi Kit (Omega Bio-Tek, Norcross, GA, USA), according to the manufacturer protocol. Schizophrenia cases and controls were mixed on the same plates, and a doubleblind procedure was used. The DNA was stored at -80°C until SNP analysis. Genotyping was performed for all SNPs using the MassARRAY platform (Sequenom, San Diego, CA, USA). SNPs were genotyped using high throughput, matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Subsequently, the resulting spectra were processed using the Typer Analyzer software (Sequenom), and genotype data were generated from the samples. Because the final genotype call rate of each SNP was greater than 95% and the overall genotyping call rate was 98.6%, the reliability of additional statistical analysis was ensured.
Statistical analysis
Allele and genotype frequencies for each individual polymorphism and Hardy-Weinberg equilibrium were evaluated using the chi-squared test. The associations between the casecontrol status and each polymorphism were assessed using the Fisher exact test or Pearson chi-square test. Unconditional logistic regression was used to calculate the odds ratio and 95% confidence interval of the independent association between each locus and the presence of schizophrenia. The gender and age of the subjects were treated as covariants in binary logistic regression. P values were calculated based on the codominant, dominant for the rare allele, heterosis and recessive for the rare allele models of inheritance. Pairwise linkage disequilibrium statistics (D' and r 2 ) and haplotype frequencies were computed using Haploview 4.0 to construct haplotype blocks. All statistical analyses were performed using the SPSS 16.0 software (SPSS Inc., Chicago, IL, USA).
RESULTS
The distribution frequencies of 9 genotyped SNPs were consistent with Hardy-Weinberg equilibrium. The analysis of strong linkage disequilibrium in the schizophrenia patients and the healthy controls revealed that 2 SNPs (rs1530351, rs4791230), 4 SNPs (rs8077696, rs8070231, rs2869577, rs2292593) and 4 SNPs (rs2292592, rs9916525, rs1122079, rs4790953) were located in haplotype block 1, block 2, and block 3, respectively (D' > 0.9) (Figure 1) . The genotype distribution, allelic frequencies, and haplotypes of schizophrenia patients and healthy controls are shown in Tables 1-4. The difference in the distribution of genotype frequencies of rs4791230 (Promoter) between schizophrenia subjects and healthy controls was significant (P = 0.010). Schizophrenia subjects showed a significantly higher frequency of the G allele (P = 0.030, odds ratio = 1.589, 95% confidence interval = 1.042-2.422); however, this finding was insignificant after Bonferroni's correction.
The T-A (rs1530351-rs4791230) haplotype was observed significantly less frequently (P = 0.029) in subjects with schizophrenia. These differences retained statistical significance after Bonferroni's correction. Table 4 . RGS9 haplotype in block 3 frequencies and the results of their associations with risk of schizophrenia.
a Based on comparison of frequency distribution of all haplotypes for the combination of SNPs. Alpha value is adjusted by Bonferroni's correction and statistically significant results (P < 0.0125).
